Benzene, 1,2,4-trichloro-
RTECS #
DC2100000
CAS #
Updated
July 2014
Molecular Weight
181.44
Molecular Formula
C6H3Cl3
Synonyms
1,2,4-Trichlorobenzene
1,2,4-Trichlorobenzene (ACGIH)
1,2,4-Trichlorobenzol
1,2,5-Trichlorobenzene
1,3,4-Trichlorobenzene
Hostetex L-pec
Trojchlorobenzen (Polish)
unsym-Trichlorobenzene
1,2,4-Trichlorobenzene (ACGIH)
1,2,4-Trichlorobenzol
1,2,5-Trichlorobenzene
1,3,4-Trichlorobenzene
Hostetex L-pec
Trojchlorobenzen (Polish)
unsym-Trichlorobenzene
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
skin /rabbit | 1950 mg/13W- intermittent | moderate | AEHLAU 30,165,1975 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
micronucleus test | intraperitoneal/mouse | 210 mg/kg/24H | MUTAEX 2,111,1987 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | 750 mg/kg (3D prior to copulation) | Reproductive: Maternal effects: Uterus, cervix, vagina | JTEHD6 8,489,1981 |
oral/rat | 3600 mg/kg (multigeneration) | Reproductive: Other effects on male Reproductive: Other effects on female Reproductive: Effects on newborn: Other neonatal measures or effects | HPV173 -,-,2002 |
oral/rat | 1800 mg/kg (9-13D pregnant) | Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death | ENVRAL 31,362,1983 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 2336 gm/kg/2Y- continuous | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors | NTIS** OTS0571797 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Human, melanoma | Inhibitor Concentration (50 percent kill): >2500 mg/L/48H | In Vitro Toxicity Studies: Cell viability (lysosomal damage): neutral red assay etc. | FCTOD7 50,2084,2012 |
inhalation/mammal (species unspecified) | lowest published toxic concentration: 200 mg/m3 | Behavioral: Alteration of classical conditioning | VCVGK* -,26,1984 |
intraperitoneal/mouse | lethal dose (50 percent kill): 1223 mg/kg | MUTAEX 2,111,1987 | |
intraperitoneal/rat | lowest published toxic dose: 2 mg/kg | Kidney, Ureter, and Bladder: Changes in kidney weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXAPA9 111,69,1991 |
intraperitoneal/rat | lowest published toxic dose: 1 mg/kg | Liver: Other changes Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | TXAPA9 111,69,1991 |
oral/mouse | lethal dose (50 percent kill): 756 mg/kg | VCVGK* -,26,1984 | |
oral/mouse | lethal dose (50 percent kill): 300 mg/kg | Behavioral: Altered sleep time (including change in righting reflex) Behavioral: Convulsions or effect on seizure threshold Behavioral: Ataxia | NAIZAM 29,569,1978 |
oral/rat | lethal dose (50 percent kill): 756 mg/kg | Behavioral: Somnolence (general depressed activity) Behavioral: Convulsions or effect on seizure threshold | AOHYA3 12,209,1969 |
oral/rat | lethal dose (50 percent kill): 756 mg/kg | HPV173 -,-,2002 | |
skin/rabbit | lowest published lethal dose: 6100 mg/kg | VCVGK* -,26,1984 | |
skin/rat | lethal dose (50 percent kill): 6139 mg/kg | HPV173 -,-,2002 | |
skin/rat | lethal dose (50 percent kill): 6139 mg/kg | Behavioral: Somnolence (general depressed activity) Behavioral: Convulsions or effect on seizure threshold | AOHYA3 12,209,1969 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/human | lowest published toxic concentration: 100 mg/m3/4Y- intermittent | Behavioral: Headache Liver: Other changes Blood: Changes in cell count (unspecified) | VCVGK* -,27,1994 |
inhalation/mouse | lowest published toxic concentration: 500 mg/m3/7H/3W- intermittent | Liver: Fatty liver degeneration Blood: Changes in cell count (unspecified) Nutritional and Gross Metabolic: Weight loss or decreased weight gain | VCVGK* -,27,1994 |
inhalation/rat | lowest published toxic concentration: 100 mg/m3/17W- intermittent | Blood: Changes in leukocyte (WBC) count | VCVGK* -,27,1994 |
inhalation/rat | lowest published toxic concentration: 25 ppm/26W- intermittent | Liver: Other changes | VCVGK* -,27,1994 |
oral/mouse | lowest published toxic dose: 13104 mg/kg/26W- continuous | Liver: Other changes Liver: Tumors | CMSHAF 1,279,1972 |
oral/mouse | lowest published toxic dose: 6048 mg/kg/12W- continuous | Liver: Other changes Liver: Changes in liver weight | CMSHAF 1,153,1972 |
oral/rat | lowest published toxic dose: 280 mg/kg/14D- continuous | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | TXAPA9 37,170,1976 |
oral/rat | lowest published toxic dose: 7380 mg/kg/13W- continuous | Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in bladder weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | DCTODJ 11,11,1988 |
oral/rat | lowest published toxic dose: 280 mg/kg/14D- intermittent | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) | BCPCA6 27,361,1978 |
oral/rat | lowest published toxic dose: 181 mg/kg/2W- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases | VCVGK* -,27,1994 |
skin/mammal (species unspecified) | lowest published toxic dose: 840 mg/kg/4W- intermittent | Kidney, Ureter, and Bladder: Other changes in urine composition Biochemical: Metabolism (intermediary): Porphyrin including bile pigments | VCVGK* -,26,1994 |
skin/mammal (species unspecified) | lowest published toxic dose: 12600 mg/kg/4W- intermittent | Liver: Hepatitis (hepatocellular necrosis), diffuse | VCVGK* -,26,1994 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-ceiling concentration 5 ppm | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | MUREAV 721,27,2011 | |
TOXICOLOGY REVIEW | MUREAV 763,36,2014 |
Standards and Regulations
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO 1,2,4-TRICHLOROBENZENE-air | ceiling concentration 5 ppm | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 83334; Number of Industries 6; Total Number of Facilities 78; Number of Occupations 14; Total Number of Employees Exposed 4033; Total Number of Female Employees Exposed 1463 | |
National Occupational Hazard Survey 1974 | Hazard Code 83334; Number of Industries 4; Total Number of Facilities 74; Number of Occupations 8; Total Number of Employees Exposed 1687 |
Status in Federal Agencies
Organization | Reference |
---|---|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE | FEREAC 47,26992,82 |
EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
EPA TSCA Section 8(d) unpublished health/safety studies | |
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
NIOSH Analytical Method, 1994: Polychlorobenzenes, 5517 | |
On EPA IRIS database |
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health